Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 08/24 11:58:30 am
1654.5 GBp   -0.45%
08/22 UK dividends lagging behind UK
08/22 UK dividends lagging behind
08/18 GlaxoSmithKline Sells Dermatology Foam Products Portfolio To Mayn..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
08/22 UK dividends lagging behind UK
08/22 UK dividends lagging behind
08/20 Cipla, godrej recognised in fortune `change the world' list
08/19 GLAXOSMITHKLINE PAKISTAN : Board meeting of GlaxoSmithKline Pakistan Limited to ..
08/19 Cipla, godrej consumer products in fortune's `change the world' list
08/18 Charles River Laboratories Announces Partnership with the Milner Therapeutics..
08/18 GlaxoSmithKline Sells Dermatology Foam Products Portfolio To Mayne
08/16 GLAXOSMITHKLINE PAKISTAN : Loss of Shares of GlaxoSmithKline Pakistan Limited
08/16 GLAXOSMITHKLINE : ViiV starts PhIII Programme for dolutegravir & 3TC
08/16 GLAXOSMITHKLINE : ViiV Healthcare launches phase III programme evaluating a two-..
More news
Sector news : Pharmaceuticals - NEC
11:34aDJPFIZER : Buys Part of AstraZeneca's Antibiotics Business -- 2nd Update
10:32aDJASTRAZENECA : Sells Part of its Antibiotics Business to Pfizer -- Update
10:15aDJPfizer Buys Part of AstraZeneca's Antibiotics Business
09:48a ASTRAZENECA : Pfizer to buy antibiotics business from AstraZeneca
09:03aDJASTRAZENECA : Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Bill..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/23 10 HIV+ patients from CytoDyn's mid-stage study reach two years of complete v..
08/16 Biotechnology Dogs Move Big Pharma Off Healthcare Top Slots In August
08/16 CVRx Holds Its Nerve
08/16 Inovio Zika Phase 1 Clinical Trial Design Superior To NIH Zika Phase 1 Clinic..
08/16 ViiV Healthcare initiates late-stage development of two-drug HIV regimen
Advertisement
Financials ( GBP)
Sales 2016 26 815 M
EBIT 2016 7 264 M
Net income 2016 2 682 M
Debt 2016 13 195 M
Yield 2016 4,81%
P/E ratio 2016 35,33
P/E ratio 2017 21,88
EV / Sales 2016 3,51x
EV / Sales 2017 3,69x
Capitalization 81 019 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 17,2  GBP
Spread / Average Target 3,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC21.19%106 755
JOHNSON & JOHNSON16.28%326 773
ROCHE HOLDING LTD.-12.26%219 257
NOVARTIS AG-9.97%214 603
PFIZER INC.8.71%212 844
MERCK & CO., INC.20.37%175 812
More Results